福瑞医科

300049 SZSE 证监会行业分类 C35专用设备制造业

Key Metrics

Market Cap

13.7B ($2.0B)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

1.3B

Net Income

196.0M

Gross Margin

N/A

Op. Margin

20.6%

Net Margin

14.5%

ROE

9.2%

ROA

6.4%

D/E

0.44

Dividend Yield

N/A

EPS

0.43

Current Ratio

4.12

Price History

Company Info

Industry	C35专用设备制造业
Market Segment	ChiNext
Currency	CNY
Fiscal Year	2024

Business Overview

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 福瑞医科

Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company operates in two segments: pharmaceutical production and sales; and diagnostic equipment R&D, production and sales. The pharmaceutical production and sales segment produces and sells products, such as Fufang Biejiaruangan tablets and shell fat capsules. The diagnostic equipment R&D, production and sales segment develops, produces, and sells the FibroScan series of liver fibrosis diagnostic instruments; and FibroMeter series of blood test analysis tools for evaluating chronic liver disease. It provides digital health management services; and prescription drugs. The company was formerly known as Inner Mongolia FuRui Pharmaceutical Limited Liability Company. Inner Mongolia Furui Medical Science Co., Ltd. was founded in 1998 and is headquartered in Beijing, China.

Ticker	300049
Exchange	SZSE
Sector	证监会行业分类
Industry	C35专用设备制造业